Dipen Patel - Concepedia

Author

Dipen Patel

Pharmerit (United States)ORCID

Also Known As

D Patel, D. Patel, D.A. Patel, Dipen A Patel, Dipen A. Patel, Dipen Patel, Diya V Patel, Patel, Dipen

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Pharmerit (United States)Pfizer (United States)Virginia Commonwealth University Merck & Co., Inc., Rahway, NJ, USA (United States)Health Economics and Outcomes Research (United Kingdom)

About

Dipen Patel is an author at Pharmerit (United States) specializing in medicine, food policy, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	192
2	Health Sciences	1	1	10
3	Public Health	1	1	182
4	Allergy	1	1	182
5	Allergy Medicine	1	1	182

Dipen Patel

Publications

558

Citations

H-Index

Page 1

	Year	Citations
Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States Dipen Patel, David A. Holdford, Eric S. Edwards, Journal of Allergy and Clinical Immunology Food AllergyAllergyHealth EconomicsDietary ExposureAllergy Medicine	2011	182
Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact Keith S. Kaye, Dipen Patel, Jennifer Stephens, PLoS ONE	2015	93
Cost-Effectiveness of Alemtuzumab in the Treatment of Relapsing Forms of Multiple Sclerosis in the United States Viktor Chirikov, Ingrid Ma, Namita Joshi, Value in Health	2018	31
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective Adnan Alsumali, Laurence Djatche, Andrew Briggs, PharmacoEconomics	2021	31
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus Dipen Patel, Andrew F. Shorr, Jean Chastre, Critical Care	2014	24
Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event Adnan Alsumali, Dominik Lautsch, Rongzhe Liu, Advances in Therapy	2021	24
US hospital database analysis of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host Dipen Patel, Xin Gao, Jennifer Stephens, Journal of Medical Economics	2011	23
Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients Shan Jiang, Kala Hill, Dipen Patel, Journal of Medical Economics	2017	21
Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States Marc A. Riedl, Aleena Banerji, Michael Manning, Orphanet Journal of Rare Diseases	2018	21
Evaluating Drug Cost per Response with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus. Janice Lopez, Brian Macomson, V. Ektare, PubMed	2015	18

Page 1